COMMUNIQUÉS West-GlobeNewswire

Tetra Bio-Pharma Closes Financing With Aphria Inc.
30/11/2018
With increased cash Tetra will ramp up Drug Development Activities ORLEANS, Ontario, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc (“ Tetra ” or “ TBP ”), (TSX VENTURE: TBP) (OTCQB: TBPMF), has closed a private [...]
QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs
30/11/2018
Partners discuss efforts to accelerate precision medicine solutions at ASH 2018 HILDEN, Germany and GERMANTOWN, Md. and FORT MYERS, Fla., Nov. 30, 2018 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime [...]
Change in the number of shares and votes in Oasmia Pharmaceutical AB (publ)
30/11/2018
Oasmia Pharmaceutical AB (publ) (”Oasmia” or ”Company” or “Group”) on 29 November 2017 and on 7 September 2018, issued convertible loans with total nominal amount of MSEK 28 and MSEK 35.2 respectively. In total circa [...]
Akari Therapeutics Announces New Data Highlighting Differentiation of Drug Candidate Coversin
30/11/2018
Planned introduction of patient-friendly pen auto-injector in 2019 designed to increase comfort and convenience of treatment across the entire Akari subcutaneous program Second eculizumab-resistant patient with [...]
Share issue / transfer and annulment of shares in connection with the reduction of the quantity of shares in Nexstim Plc
30/11/2018
Company announcement, Helsinki, 30 November 2018 at 17:30 Share issue / transfer and annulment of shares in connection with the reduction of the quantity of shares in Nexstim Plc The Extraordinary General Meeting of [...]
Olainfarm increases profitability and earns 7.5 million euros in nine months
30/11/2018
Unaudited consolidated Income Statement of JSC Olainfarm for nine months of 2018 shows that the sales of the Group have reached 89.5 million euros, which is a slight decrease by 1% compared to the same period of 2017. [...]
JSC Olainfarm Strengthens the Boards of Several Daughter Companies
30/11/2018
Board of JSC Olainfarm has decided to make some changes to Management Boards of Silvanols LLC, Latvijas Aptieka LLC and Tonus Elast LLC. Larisa Podlesnaja has left the Management Board of Tonus Elast to continue in [...]
Coherus BioSciences Announces Apexus Contract Agreement for 340B Hospitals and Clinics, and Q-Code Issuance from CMS
30/11/2018
REDWOOD CITY, Calif., Nov. 30, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that the company has executed a 340B prime vendor program contract agreement with Apexus, LLC. Apexus is [...]
HEXO scoops two prizes at 2018 Canadian Cannabis Awards
30/11/2018
GATINEAU, Quebec, Nov. 30, 2018 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX:HEXO) was honoured for product innovation with two prestigious Canadian Cannabis Awards at the 2018 gala. Hydropothecary by [...]
HEXO remporte deux prix aux Canadian Cannabis Awards 2018
30/11/2018
GATINEAU, Québec, 30 nov. 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (« HEXO » ou la « Société ») (TSX:HEXO ) a été honoré pour l'innovation de ses produits avec deux prestigieux prix canadiens du cannabis lors du gala de 2018 [...]
Clementia Announces the Departure of Chief Commercial Officer
30/11/2018
MONTREAL, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA), a clinical-stage biopharmaceutical company innovating treatments for people with ultra-rare bone disorders and other diseases, [...]
Clementia annonce le départ de son chef de la direction commerciale
30/11/2018
MONTRÉAL, 30 nov. 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq : CMTA), une société biopharmaceutique au stade clinique proposant des traitements novateurs pour les personnes atteintes de troubles [...]
WW to Present at Nasdaq 39th Investor Conference
30/11/2018
NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (Nasdaq: WTW) (“WW”), a global wellness company and the world’s leading commercial weight management program, today announced that Nick [...]
Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of Presentations at the 2018 American Epilepsy Society (AES) Meeting
30/11/2018
BURNABY, British Columbia, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it will host a conference call and live audio [...]
Radius Health Provides Updates on its Oncology Programs and Announces Scientific Presentations at 2018 San Antonio Breast Cancer Symposium (SABCS)
30/11/2018
Phase 3 elacestrant study has opened for enrollment Fast Track designation from the FDA for the Phase 3 study population Elacestrant pre-clinical data demonstrates further evidence of anti-tumor activity in breast [...]
Glass Lewis Recommends that Keryx Biopharmaceuticals Stockholders Vote “FOR” the Proposed Merger with Akebia Therapeutics
30/11/2018
BOSTON, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced that leading [...]
Agility Health Reports Third Quarter 2018 Financial Results
30/11/2018
HAMILTON, Ontario, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV: AHI) (“ Agility Health ” or “ Corporation ”), a leading provider of orthotics, prosthetics and foot care services, today reported its [...]
Holding(s) in Company
30/11/2018
TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the [...]
Vilacto Bio Secured Patent Applications for LACTOACTIVE®
30/11/2018
NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- New York-based Vilacto Bio Inc. (OTC QB:VIBI) has secured the patent applications for LACTOACTIVE® covering rights in the US, Canada Europe and Hong Kong. The transaction was [...]

Pages